Greenleaf Peter bought AUPH
January 2, 2026 · Form 4 insider transaction
Greenleaf Peter bought 165,384 shares of Aurinia Pharmaceuticals Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
165,384
Price
$0.00
Total value
N/A
InsiderGreenleaf Peter
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2026
Filing dateJanuary 5, 2026
Shares owned after1,954,329
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the number of shares earned upon certification of performance for a performance award payable solely in common shares of the Issuer that vest in two (2) equal annual installments on December 31, 2025 and December 31, 2026.